![Albumin Binder–Conjugated Fibroblast Activation Protein Inhibitor Radiopharmaceuticals for Cancer Therapy | Journal of Nuclear Medicine Albumin Binder–Conjugated Fibroblast Activation Protein Inhibitor Radiopharmaceuticals for Cancer Therapy | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/63/6/952/F1.large.jpg)
Albumin Binder–Conjugated Fibroblast Activation Protein Inhibitor Radiopharmaceuticals for Cancer Therapy | Journal of Nuclear Medicine
![Clickable” Albumin Binders for Modulating the Tumor Uptake of Targeted Radiopharmaceuticals | Journal of Medicinal Chemistry Clickable” Albumin Binders for Modulating the Tumor Uptake of Targeted Radiopharmaceuticals | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.1c01791/asset/images/large/jm1c01791_0004.jpeg)
Clickable” Albumin Binders for Modulating the Tumor Uptake of Targeted Radiopharmaceuticals | Journal of Medicinal Chemistry
![Pharmaceuticals | Free Full-Text | New 55Co-labeled Albumin-Binding Folate Derivatives as Potential PET Agents for Folate Receptor Imaging Pharmaceuticals | Free Full-Text | New 55Co-labeled Albumin-Binding Folate Derivatives as Potential PET Agents for Folate Receptor Imaging](https://pub.mdpi-res.com/pharmaceuticals/pharmaceuticals-12-00166/article_deploy/html/images/pharmaceuticals-12-00166-ag.png?1577741295)
Pharmaceuticals | Free Full-Text | New 55Co-labeled Albumin-Binding Folate Derivatives as Potential PET Agents for Folate Receptor Imaging
![Albumin binding Nanofitins, a new scaffold to extend half-life of biologics – a case study with exenatide peptide - ScienceDirect Albumin binding Nanofitins, a new scaffold to extend half-life of biologics – a case study with exenatide peptide - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0196978122000262-ga1.jpg)
Albumin binding Nanofitins, a new scaffold to extend half-life of biologics – a case study with exenatide peptide - ScienceDirect
![Mini-review: Targeted radiopharmaceuticals incorporating reversible, low molecular weight albumin binders - ScienceDirect Mini-review: Targeted radiopharmaceuticals incorporating reversible, low molecular weight albumin binders - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0969805118303627-gr1.jpg)
Mini-review: Targeted radiopharmaceuticals incorporating reversible, low molecular weight albumin binders - ScienceDirect
![Non-covalent albumin-binding ligands for extending the circulating half-life of small biotherapeutics - MedChemComm (RSC Publishing) DOI:10.1039/C9MD00018F Non-covalent albumin-binding ligands for extending the circulating half-life of small biotherapeutics - MedChemComm (RSC Publishing) DOI:10.1039/C9MD00018F](https://pubs.rsc.org/image/article/2019/MD/c9md00018f/c9md00018f-f2_hi-res.gif)
Non-covalent albumin-binding ligands for extending the circulating half-life of small biotherapeutics - MedChemComm (RSC Publishing) DOI:10.1039/C9MD00018F
![The Effect of Albumin-Binding Moiety on Tumor Targeting and Biodistribution Properties of 67Ga-Labeled Albumin Binder-Conjugated Alpha-Melanocyte-Stimulating Hormone Peptides | Cancer Biotherapy and Radiopharmaceuticals The Effect of Albumin-Binding Moiety on Tumor Targeting and Biodistribution Properties of 67Ga-Labeled Albumin Binder-Conjugated Alpha-Melanocyte-Stimulating Hormone Peptides | Cancer Biotherapy and Radiopharmaceuticals](https://www.liebertpub.com/cms/10.1089/cbr.2021.0273/asset/images/medium/cbr.2021.0273_figure1.jpg)
The Effect of Albumin-Binding Moiety on Tumor Targeting and Biodistribution Properties of 67Ga-Labeled Albumin Binder-Conjugated Alpha-Melanocyte-Stimulating Hormone Peptides | Cancer Biotherapy and Radiopharmaceuticals
![Evans blue-modified radiolabeled fibroblast activation protein inhibitor as long-acting cancer therapeutics Evans blue-modified radiolabeled fibroblast activation protein inhibitor as long-acting cancer therapeutics](https://www.thno.org/v12/p0422/toc.jpg)
Evans blue-modified radiolabeled fibroblast activation protein inhibitor as long-acting cancer therapeutics
![177Lu-Labeled Phosphoramidate-Based PSMA Inhibitors: The Effect of an Albumin Binder on Biodistribution and Therapeutic Efficacy in Prostate Tumor-Bearing Mice 177Lu-Labeled Phosphoramidate-Based PSMA Inhibitors: The Effect of an Albumin Binder on Biodistribution and Therapeutic Efficacy in Prostate Tumor-Bearing Mice](https://www.thno.org/v07/p1928/toc.jpg)
177Lu-Labeled Phosphoramidate-Based PSMA Inhibitors: The Effect of an Albumin Binder on Biodistribution and Therapeutic Efficacy in Prostate Tumor-Bearing Mice
Exploring the Influence of Different Albumin Binders on Molecular Imaging Probe Distribution | Molecular Pharmaceutics
![PDF] DOTA Conjugate with an Albumin-Binding Entity Enables the First Folic Acid–Targeted 177Lu-Radionuclide Tumor Therapy in Mice | Semantic Scholar PDF] DOTA Conjugate with an Albumin-Binding Entity Enables the First Folic Acid–Targeted 177Lu-Radionuclide Tumor Therapy in Mice | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/61027e6917440bb2bde8ae490941071f41705bc8/2-Figure1-1.png)
PDF] DOTA Conjugate with an Albumin-Binding Entity Enables the First Folic Acid–Targeted 177Lu-Radionuclide Tumor Therapy in Mice | Semantic Scholar
![Genetically encoded discovery of perfluoroaryl macrocycles that bind to albumin and exhibit extended circulation in vivo | Nature Communications Genetically encoded discovery of perfluoroaryl macrocycles that bind to albumin and exhibit extended circulation in vivo | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-023-41427-y/MediaObjects/41467_2023_41427_Fig1_HTML.png)
Genetically encoded discovery of perfluoroaryl macrocycles that bind to albumin and exhibit extended circulation in vivo | Nature Communications
![Radioiodinated Portable Albumin Binder as a Versatile Agent for in Vivo Imaging with Single-Photon Emission Computed Tomography | Molecular Pharmaceutics Radioiodinated Portable Albumin Binder as a Versatile Agent for in Vivo Imaging with Single-Photon Emission Computed Tomography | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.8b01116/asset/images/medium/mp-2018-01116j_0007.gif)
Radioiodinated Portable Albumin Binder as a Versatile Agent for in Vivo Imaging with Single-Photon Emission Computed Tomography | Molecular Pharmaceutics
![Bench to Bedside: Albumin Binders for Improved Cancer Radioligand Therapies | Bioconjugate Chemistry Bench to Bedside: Albumin Binders for Improved Cancer Radioligand Therapies | Bioconjugate Chemistry](https://pubs.acs.org/cms/10.1021/acs.bioconjchem.8b00919/asset/images/medium/bc-2018-00919s_0001.gif)
Bench to Bedside: Albumin Binders for Improved Cancer Radioligand Therapies | Bioconjugate Chemistry
Non-covalent albumin-binding ligands for extending the circulating half-life of small biotherapeutics - MedChemComm (RSC Publishing)
![Head-to-head comparison of different classes of FAP radioligands designed to increase tumor residence time: monomer, dimer, albumin binders, and small molecules vs peptides | European Journal of Nuclear Medicine and Molecular Imaging Head-to-head comparison of different classes of FAP radioligands designed to increase tumor residence time: monomer, dimer, albumin binders, and small molecules vs peptides | European Journal of Nuclear Medicine and Molecular Imaging](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00259-023-06272-7/MediaObjects/259_2023_6272_Fig1_HTML.png)
Head-to-head comparison of different classes of FAP radioligands designed to increase tumor residence time: monomer, dimer, albumin binders, and small molecules vs peptides | European Journal of Nuclear Medicine and Molecular Imaging
![Radioiodinated Portable Albumin Binder as a Versatile Agent for in Vivo Imaging with Single-Photon Emission Computed Tomography | Molecular Pharmaceutics Radioiodinated Portable Albumin Binder as a Versatile Agent for in Vivo Imaging with Single-Photon Emission Computed Tomography | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.8b01116/asset/images/medium/mp-2018-01116j_0001.gif)
Radioiodinated Portable Albumin Binder as a Versatile Agent for in Vivo Imaging with Single-Photon Emission Computed Tomography | Molecular Pharmaceutics
![“Clickable” Albumin Binders for Modulating the Tumor Uptake of Targeted Radiopharmaceuticals | Journal of Medicinal Chemistry “Clickable” Albumin Binders for Modulating the Tumor Uptake of Targeted Radiopharmaceuticals | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.1c01791/asset/images/medium/jm1c01791_0014.gif)